Pioneering Mito-1041: A Novel siRNA Approach to Modulate Mitochondrial Function for Tissue Selectivity & Specificity
Time: 11:40 am
day: CONFERENCE DAY TWO
Details:
- Transforming siRNA as a state-of-the-art therapeutic for treating mitochondrial impairment through gene specificity and organ selectivity
- Highlighting various methods of siRNA delivery to address distinguishing features of organs for restoration of mitochondrial function
- Creating a roadmap to develop MITO-1041 and related compounds as a novel, safe and effective mitochondrial therapy for treating metabolic-associated liver disease (MASH), acute liver, kidney injury and heart disease
